Webinar recording: ‘Freedom from heart failure: reimagining cardiac services in England’

News & Events

14 May 2021
AUTHOR: HFPN Admin

On Wednesday 12 May 2021, the Heart Failure Policy Network (HFPN) and the British Society for Heart Failure (BSH) co-hosted Freedom from heart failure: reimagining cardiac services in England, bringing together leading experts in cardiovascular disease to discuss the future of cardiac services.

The Chair, Mr Ed Harding (Network Director, HFPN) opened the webinar with a brief introduction to the societal impact of heart failure. Next, Professor Nick Linker (National Clinical Director for Heart Disease, NHS England & NHS Improvement) explained the new regional structures of the NHS and cardiac services in England. Dr Simon Williams (Chair, BSH) then turned the focus to new leadership opportunities for heart failure specialists before Dr Hugh McIntyre (Chair,NICE QSAC3) explained how efforts in heart failure fit within the broader context of cardiovascular care. Finally, Dr Sonya Babu-Narayan (Associate Medical Director, British Heart Foundation) ended on an inspiring note, encouraging the heart failure clinical community to get involved and drive improvements in care for people living with heart failure and other chronic diseases. The event finished with a short Q&A session with all speakers.

Tagged:

More from News & Events

Thoughts from the front line: heart failure services during
Thoughts from the front line: heart failure services during ...
23 June 2021
In this guest blog post, heart failure nurse consultant Carys Barton shares the challenges faced and innovative solutions implemented at Imperial College Healthcare NHS Trust in Lo...
Read article
New French translation of The handbook of multidisciplinary
New French translation of The handbook of multidisciplinary ...
07 June 2021
The Heart Failure Policy Network has launched a French translation of The handbook of multidisciplinary and integrated heart failure care....
Read article
The Heart Failure Policy Network is made possible with financial support from AstraZeneca, Vifor Pharma and Novartis Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.